Forecast: Production in Pharmaceuticals, Medicinal Chemical and Botanical Products Manufacturing Sector in Italy

The Italian pharmaceutical manufacturing sector, covering pharmaceuticals, medicinal chemicals, and botanical products, saw robust growth from 2024 to 2028 with an annual increase averaging around 1.21%. In 2023, the production value stood at approximately 28.50 billion euros. From 2024 to 2025, the sector grew by 1.25%, and it continued its upward trajectory with a 1.20% increase from 2025 to 2026. Similar growth rates were observed between 2026 and 2027, and from 2027 to 2028 at 1.15% and 1.16%, respectively. The compound annual growth rate (CAGR) over the five-year period is approximately 1.21%.

Future trends to watch for include technological advancements in drug manufacturing, potential regulatory changes within the EU affecting production, and the impact of global supply chain adjustments. Additionally, increased investment in research and development is expected to drive innovation and efficiency, contributing to further growth in the sector. Monitoring the sector's adaptation to environmental sustainability initiatives will also be crucial. Moreover, demographic shifts and higher healthcare needs may escalate demand for pharmaceutical products, influencing production dynamics.